Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial
Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to the control group ( = no input from pharmacist) or intervention group ( = with pharmaceutical care at baseline and follow-up visits over 6 months).
Inclusion Criteria:
Exclusion Criteria: